Loading provider…
Loading provider…
Internal Medicine Physician in Burbank, CA
NPI: 1073689386Primary Practice Location
Comcare Primary Medical Group a California General Partnership
333 E Magnolia Blvd, Burbank, CA
Primary Employer
Comcare Primary Medical Group a California General Partnership
comcaremed1.org
HQ Phone
Get MD Hakop's Phone Numberphone_androidMobile
Get MD Hakop's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1997 - 2025

American Board of Internal Medicine
Internal Medicine
Adventist Health White Memorial
Residency • Internal Medicine
1996 - 1999
Keck School of Medicine of USC
keck.usc.edu
Medical School
Until 1996
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 229 | 229 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 222 | 402 |
| 3 | G0444Annual depression screening, 15 minutes | 217 | 217 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 159 | 282 |
| 5 | 99212Established patient outpatient visit, total time 10-19 minutes | 130 | 171 |
The effect of LCZ696 (sacubitril/valsartan) on amyloid-β concentrations in cerebrospinal fluid in healthy subjects
Authors: Thomas Langenickel, Chiaki Tsubouchi, Surya Ayalasomayajula, Parasar Pal, Marie-Anne Valentin, Markus Hinder, Stanford Jhee, Hakop Gevorkyan, Iris Rajman
Publication Date: 2016-05
Authors: Sherif El-Harazi
Journal: Drug Saf
Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033
Authors: Tran, Jonathan Q, Rana, Jitesh, Barkhof, Frederik, Melamed, Isaac, Gevorkyan, Hakop, Wattjes, Mike P, de Jong, Remko, Brosofsky, Kristin, Ray, Soma, Xu, Lei, Zhao, Jim, Parr, Edward, Cadavid, Diego
Journal: Neurol Neuroimmunol Neuroinflamm
Publication Date: 2014-08-21
Lead Sponsor: ViiV Healthcare
Collaborators: GlaxoSmithKline, Janssen Pharmaceuticals
Intervention / Treatment: DRUG: Cabotegravir Tablets, DRUG: Rilpivirine Tablets, DRUG: Cabotegravir extended release suspension for injection (long-acting), DRUG: Rilpivirine extended release suspension for injection (long-acting)
Lead Sponsor: The National Institutes of Pharmaceutical R&D Co. Ltd, China
Intervention / Treatment: DRUG: NIP292 tablet, DRUG: NIP292 tablets
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Dulaglutide